|
Market Closed -
Nasdaq
16:00:00 2026-11-06 EST
|
5-day change | 1st Jan Change | ||
| 21.23 USD | -0.05% |
|
+3.11% | -20.52% |
| 11-06 | Deutsche Bank Adjusts ACADIA Pharmaceuticals PT to $30 From $31, Maintains Buy Rating | MT |
| 11-06 | RBC Raises Price Target on Acadia Healthcare to $41 From $31, Keeps Outperform Rating | MT |
| Market Cap | 3.67B 3.29B 3.01B 2.75B 5.17B 345B 5.34B 36.25B 14.46B 184B 13.77B 13.48B 581B | P/E 2026 * |
28.9x | P/E 2027 * | 22.2x |
|---|---|---|---|---|---|
| Enterprise Value | 2.66B 2.39B 2.18B 1.99B 3.75B 250B 3.87B 26.28B 10.48B 133B 9.99B 9.77B 421B | EV / Sales 2026 * |
2.08x | EV / Sales 2027 * | 1.75x |
| Free-Float |
99.67% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ACAD | Delayed | |
CBOE
| ACAD | Real-time | |
|
Mexican S.E.
| ACAD * | End-of-day quote | |
|
Tradegate
| DR6 | Real-time | |
|
Boerse Muenchen
| DR6 | Real-time | |
|
Deutsche Boerse AG
| DR6 | Delayed | |
|
Börse Stuttgart
| DR6 | Delayed |
Last Transcript: Acadia Pharmaceuticals Inc.
| 1 day | -0.05% | ||
| 1 week | +3.11% | ||
| Current month | +3.11% | ||
| 1 month | +8.04% | ||
| 3 months | -27.32% | ||
| 6 months | -5.90% | ||
| Current year | -20.52% |
| 1 week | 20.25 |  | 22.63 |
| 1 month | 18.39 | | 22.63 |
| Current year | 18.39 | | 30.96 |
| 1 year | 18.39 | | 30.96 |
| 3 years | 13.4 | | 32.59 |
| 5 years | 12.24 | | 33.99 |
| 10 years | 12.24 | | 58.72 |
| Manager | Title | Age | Since |
|---|---|---|---|
Catherine Adams
CEO | Chief Executive Officer | 55 | 2024-09-19 |
Mark Schneyer
DFI | Director of Finance/CFO | 52 | 2021-09-09 |
Scott Cenci
CTO | Chief Tech/Sci/R&D Officer | - | 2025-08-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Laura Brege
BRD | Director/Board Member | 68 | 2008-04-30 |
Stephen Biggar
CHM | Chairman | 55 | 2016-06-09 |
Edmund Harrigan
BRD | Director/Board Member | 73 | 2015-11-24 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/6/26 | Exercice | Chief Financial Officer | 42,876 | 0.0250% | ||
| 7/30/26 | Sell | Chief Technology Officer | -16,558 | 0.0097% | ||
| 5/29/26 | Exercice | Director | 41,529 | 0.0243% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.05% | +3.11% | -5.94% | -9.66% | 3.67B | |
| -4.83% | +3.51% | +55.00% | +63.79% | 65.94B | |
| +0.02% | +1.07% | +11.72% | +75.63% | 56.88B | |
| -1.34% | +2.98% | +25.08% | +100.18% | 56.53B | |
| +5.09% | +9.89% | +27.19% | +105.85% | 46.49B | |
| +2.62% | +1.68% | +29.16% | +35.86% | 44.8B | |
| +8.24% | +0.51% | +215.16% | +794.74% | 41.59B | |
| -1.86% | +10.13% | +28.14% | +55.48% | 35.35B | |
| -2.97% | -9.84% | +90.91% | +73.49% | 33.29B | |
| +5.19% | +1.62% | -39.69% | +368.87% | 25.1B | |
| Average | +1.01% | +2.69% | +43.67% | +166.42% | 40.96B | |
| Weighted average by Cap. | +0.66% | +3.07% | +49.39% | +164.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.28B 1.15B 1.05B 958M 1.8B 120B 1.86B 12.64B 5.04B 64.18B 4.8B 4.7B 203B | 1.45B 1.3B 1.19B 1.08B 2.04B 136B 2.11B 14.31B 5.71B 72.66B 5.44B 5.32B 229B |
| Net income | 132M 118M 108M 98.65M 186M 12.39B 192M 1.3B 519M 6.61B 495M 484M 20.88B | 171M 154M 140M 128M 242M 16.11B 249M 1.69B 675M 8.6B 643M 629M 27.14B |
| Net Debt | -1.01B -905M -827M -755M -1.42B -94.84B -1.47B -9.97B -3.97B -50.61B -3.79B -3.71B -160B | -1.13B -1.01B -926M -846M -1.59B -106B -1.64B -11.17B -4.45B -56.69B -4.24B -4.15B -179B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-06 | US$21.23 | -0.05% | 1,770,851 |
| 26-11-05 | US$21.24 | -1.07% | 6,027,494 |
| 26-11-04 | US$21.47 | +4.38% | 4,719,961 |
| 26-11-03 | US$20.57 | +0.49% | 1,709,205 |
| 26-11-02 | US$20.47 | -0.58% | 1,384,944 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ACAD Stock
Select your edition
All financial news and data tailored to specific country editions
